Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Catalent Inc

CTLT
Current price
55.37 USD +0.07 USD (+0.13%)
Last closed 55.25 USD
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NYSE
Capitalization 10 100 494 336 USD
Yield for 12 month +47.61 %
1Y
3Y
5Y
10Y
15Y
CTLT
21.11.2021 - 28.11.2021

Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates in two segments, Biologics, and Pharma and Consumer Health. The Biologics segment provides formulation, development, and manufacturing for biologic proteins, cell gene, and other nucleic acid therapies; pDNA, iPSCs, oncolytic viruses, and vaccines; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, and cartridges; and analytical development and testing services for large molecules. The Pharma and Consumer Health segment offers formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations; and oral, nasal, inhaled, and topical dose forms. This segment also provides clinical supply services through manufacturing, packaging, storage, distribution, and inventory management for small-molecule drugs, protein-based biologics, and cell and gene therapies in clinical trials; and pre-clinical screening, formulation, analytical development, and current good manufacturing practices manufacturing at clinical and commercial scale for softgel capsule, Zydis fast-dissolve tablets, oral solid-dose formats, dry powder inhalers, and nasal delivery devices. The company also offers FlexDirect direct-to-patient and FastChain demand-led clinical supply solutions; fill and finish operations for injectable products; and integrated development and product supply chain solutions. It serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. The company was founded in 1933 and is headquartered in Somerset, New Jersey. Address: 14 Schoolhouse Road, Somerset, NJ, United States, 08873

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

56.7 USD

P/E ratio

Dividend Yield

Current Year

+4 276 000 000 USD

Last Year

+4 828 000 000 USD

Current Quarter

+1 074 000 000 USD

Last Quarter

+1 024 000 000 USD

Current Year

+1 060 000 000 USD

Last Year

+1 640 000 000 USD

Current Quarter

+229 000 000 USD

Last Quarter

+171 000 000 USD

Key Figures CTLT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 355 000 000 USD
Operating Margin TTM 0.56 %
PE Ratio
Return On Assets TTM -0.71 %
PEG Ratio 2.0565
Return On Equity TTM -28.29 %
Wall Street Target Price 56.7 USD
Revenue TTM 4 135 000 064 USD
Book Value 19.96 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 3.6 %
Dividend Yield
Gross Profit TTM 1 040 000 000 USD
Earnings per share -6.48 USD
Diluted Eps TTM -6.48 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY -15.4 %
Profit Margin -28.44 %

Dividend Analytics CTLT

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CTLT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation CTLT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 37.8788
Enterprise Value Revenue 3.6507
Price Sales TTM 2.4831
Enterprise Value EBITDA -19.8416
Price Book MRQ 2.7598

Financials CTLT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CTLT

For 52 weeks

31.5 USD 60.2 USD
50 Day MA 56.33 USD
Shares Short Prior Month 7 511 980
200 Day MA 48.48 USD
Short Ratio 3.98
Shares Short 6 652 967
Short Percent 4.7 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

420.21 USD Microsoft Corporation -1.96 (-0.46%)
Detailed analytics

ETF funds


S

SX7EEX

14.76 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) +0.11 (+0.7%)
Detailed analytics

Metals


Gold

2441.48 USD Gold +26.8 (+1.11%)
Detailed analytics